product summary
Loading...
company name :
Novus Biologicals
other brands :
IMGENEX
product type :
antibody
product name :
HLA ABC Antibody (W6/32) - Azide and BSA Free
catalog :
NB100-64775
quantity :
0.25 mg (also 0.05 mg)
price :
479 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
W6/32
reactivity :
human, mouse
application :
western blot, ELISA, immunohistochemistry, immunoprecipitation, flow cytometry, immunohistochemistry - paraffin section, immunohistochemistry - frozen section
more info or order :
citations: 24
Reference
Yanagisawa M, Nagamatsu T, Kurano M, Misumi F, Taguchi A, Akiba N, et al. Upregulation of autotaxin by oxidative stress via Nrf2 activation: A novel insight into the compensation mechanism in preeclamptic placenta. J Reprod Immunol. 2023;160:104153 pubmed publisher
Phulphagar K, Ctortecka C, Jacome A, Klaeger S, Verzani E, Hernandez G, et al. Sensitive, High-Throughput HLA-I and HLA-II Immunopeptidomics Using Parallel Accumulation-Serial Fragmentation Mass Spectrometry. Mol Cell Proteomics. 2023;22:100563 pubmed publisher
Phulphagar K, Ctortecka C, Vaca Jacome A, Klaeger S, Verzani E, Hernandez G, et al. Sensitive, high-throughput HLA-I and HLA-II immunopeptidomics using parallel accumulation-serial fragmentation mass spectrometry. bioRxiv. 2023;: pubmed publisher
Mimura N, Nagamatsu T, Morita K, Taguchi A, Toya T, Kumasawa K, et al. Suppression of human trophoblast syncytialization by human cytomegalovirus infection. Placenta. 2022;117:200-208 pubmed publisher
Strijker J, Pscheid R, Drent E, van der Hoek J, Koopmans B, Ober K, et al. αβ-T Cells Engineered to Express γδ-T Cell Receptors Can Kill Neuroblastoma Organoids Independent of MHC-I Expression. J Pers Med. 2021;11: pubmed publisher
Javeed N, Her T, Brown M, Vanderboom P, Rakshit K, Egan A, et al. Pro-inflammatory β cell small extracellular vesicles induce β cell failure through activation of the CXCL10/CXCR3 axis in diabetes. Cell Rep. 2021;36:109613 pubmed publisher
Darwish M, Wichner S, Li J, Chang J, Tam C, Franke Y, et al. High-throughput identification of conditional MHCI ligands and scaled-up production of conditional MHCI complexes. Protein Sci. 2021;30:1169-1183 pubmed publisher
Jongsma M, de Waard A, Raaben M, Zhang T, Cabukusta B, Platzer R, et al. The SPPL3-Defined Glycosphingolipid Repertoire Orchestrates HLA Class I-Mediated Immune Responses. Immunity. 2021;54:132-150.e9 pubmed publisher
Mourier B, Labadie P, Desmet M, Grosbois C, Raux J, Debret M, et al. Combined spatial and retrospective analysis of fluoroalkyl chemicals in fluvial sediments reveal changes in levels and patterns over the last 40 years. Environ Pollut. 2019;253:1117-1125 pubmed publisher
Wang Y, Huang J, Gong L, Yu D, An C, Bunpetch V, et al. The Plasticity of Mesenchymal Stem Cells in Regulating Surface HLA-I. iScience. 2019;15:66-78 pubmed publisher
Nevens D, Duprez F, Daisne J, Dok R, Belmans A, Voordeckers M, et al. Reduction of the dose of radiotherapy to the elective neck in head and neck squamous cell carcinoma; a randomized clinical trial. Effect on late toxicity and tumor control. Radiother Oncol. 2017;122:171-177 pubmed publisher
Jones D, Kosmoliaptsis V, Apps R, Lapaque N, Smith I, Kono A, et al. HLA class I allelic sequence and conformation regulate leukocyte Ig-like receptor binding. J Immunol. 2011;186:2990-7 pubmed publisher
Zuo J, Quinn L, Tamblyn J, Thomas W, Feederle R, Delecluse H, et al. The Epstein-Barr virus-encoded BILF1 protein modulates immune recognition of endogenously processed antigen by targeting major histocompatibility complex class I molecules trafficking on both the exocytic and endocytic pathways. J Virol. 2011;85:1604-14 pubmed publisher
Fujita Y, Abe R, Inokuma D, Sasaki M, Hoshina D, Natsuga K, et al. Bone marrow transplantation restores epidermal basement membrane protein expression and rescues epidermolysis bullosa model mice. Proc Natl Acad Sci U S A. 2010;107:14345-50 pubmed publisher
Narita M, Masuko M, Kurasaki T, Kitajima T, Takenouchi S, Saitoh A, et al. WT1 peptide vaccination in combination with imatinib therapy for a patient with CML in the chronic phase. Int J Med Sci. 2010;7:72-81 pubmed
Vitadello M, Doria A, Tarricone E, Ghirardello A, Gorza L. Myofiber stress-response in myositis: parallel investigations on patients and experimental animal models of muscle regeneration and systemic inflammation. Arthritis Res Ther. 2010;12:R52 pubmed publisher
Hinrichs J, Föll D, Bade Döding C, Huyton T, Blasczyk R, Eiz Vesper B. The nature of peptides presented by an HLA class I low expression allele. Haematologica. 2010;95:1373-80 pubmed publisher
Spentzou A, Bergin P, Gill D, Cheeseman H, Ashraf A, Kaltsidis H, et al. Viral inhibition assay: a CD8 T cell neutralization assay for use in clinical trials of HIV-1 vaccine candidates. J Infect Dis. 2010;201:720-9 pubmed publisher
Grotzke J, Harriff M, Siler A, Nolt D, Delepine J, Lewinsohn D, et al. The Mycobacterium tuberculosis phagosome is a HLA-I processing competent organelle. PLoS Pathog. 2009;5:e1000374 pubmed publisher
Koene G, Arts Hilkes Y, van Dijk A, van der Ven K, Slootweg P, de Weger R, et al. High level of aneuploidy of chromosome 6 by FISH analysis of head and neck squamous cell carcinoma: limited applicability of LOH analysis to define HLA loss. Hum Immunol. 2004;65:1455-62 pubmed
Dressel R, Grzeszik C, Kreiss M, Lindemann D, Herrmann T, Walter L, et al. Differential effect of acute and permanent heat shock protein 70 overexpression in tumor cells on lysability by cytotoxic T lymphocytes. Cancer Res. 2003;63:8212-20 pubmed
Ishitani A, Sageshima N, Lee N, Dorofeeva N, Hatake K, Marquardt H, et al. Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition. J Immunol. 2003;171:1376-84 pubmed
Goldman Wohl D, Ariel I, Greenfield C, Hochner Celnikier D, Lavy Y, Yagel S. A study of human leukocyte antigen G expression in hydatidiform moles. Am J Obstet Gynecol. 2001;185:476-80 pubmed
Yoshino N, Ami Y, Terao K, Tashiro F, Honda M. Upgrading of flow cytometric analysis for absolute counts, cytokines and other antigenic molecules of cynomolgus monkeys (Macaca fascicularis) by using anti-human cross-reactive antibodies. Exp Anim. 2000;49:97-110 pubmed
product information
master code :
NB100-64775
SKU :
NB100-64775
product name :
HLA ABC Antibody (W6/32) - Azide and BSA Free
unit size :
0.25 mg (also 0.05 mg)
description :
The HLA ABC Antibody (W6/32) - Azide and BSA Free from Novus is a mouse monoclonal antibody to HLA ABC. This antibody reacts with human,mouse. The HLA ABC Antibody (W6/32) - Azide and BSA Free has been validated for the following applications: Functional,ELISA,Immunoprecipitation,Western Blot,Immunohistochemistry-Paraffin,Immunohistochemistry-Frozen,Magnetic Cell Separation,Flow Cytometry,Immunohistochemistry,Immunohistochemistry-Paraffin (Negative),CyTOF-ready.
target :
HLA ABC
category :
Primary Antibodies
buffer :
PBS
clonality :
Monoclonal
clone :
W6/32
concentration :
1 mg/ml
conjugate :
Unconjugated
host :
Mouse
immunogen :
Purified human tonsil lymphocyte membranes
isotype :
IgG2a
purity :
Protein A purified
species :
Human,Mouse
specificity :
NB100-64775 recognizes an antigenic determinant shared among products of the HLA A, B and C loci
gene symbol :
HLA-A
applications :
Functional,ELISA,Immunoprecipitation,Western Blot,Immunohistochemistry-Paraffin,Immunohistochemistry-Frozen,Magnetic Cell Separation,Flow Cytometry,Immunohistochemistry,Immunohistochemistry-Paraffin (Negative),CyTOF-ready
USD :
479 USD
alt names :
A-10 alpha chain, FLJ26655, HLA class I histocompatibility antigen, A-1 alpha chain, HLA class I histocompatibility antigen, A-28 alpha chain, HLA class I histocompatibility antigen, A-9 alpha chain, HLAA, major histocompatibility complex, class I, A, MHC class I antigen A*1, MHC class I antigen A*11, MHC class I antigen A*80
storage :
Store at -20C. Avoid freeze-thaw cycles.
more info or order :
company information
Novus Biologicals
10771 E Easter Ave
Centennial, CO 80112
novus@novusbio.com
https://www.novusbio.com
3037301950
headquarters: USA
Novus Biologicals licenses, manufactures, and markets antibodies to over 20,000 unique targets to support a wide array of research areas. Novus is built on honesty, collaboration and strong relationships and continues to provide quality tools that accelerate research. Every product is backed by our 100% guarantee.